Human and experimental hepatocarcinogenesis

Area of Science:

• Hepatology and Carcinogenesis
• Comparative Pathology
• Oncology

Background:

• Human liver cancer incidence is rising globally, necessitating early detection for effective treatment.
• Premalignant and early malignant liver lesions require better understanding for therapeutic intervention.
• Existing animal models offer insights into liver tumor development and progression.

Purpose of the Study:

• To compare experimentally induced hepatomas with human liver lesions.
• To identify common molecular and phenotypic changes in liver cancer development.
• To evaluate the utility of animal models in studying human liver cancer.

Main Methods:

• Utilized MC-29 virus-induced chicken hepatoma model.
• Employed rodent, fish, and monkey models for chemical hepatocarcinogenesis.
• Analyzed phenotypic enzyme alterations and oncogene/growth factor expression.

Main Results:

• Experimentally induced hepatomas show phenotypic enzyme changes and altered oncogene/growth factor expression, mirroring human lesions.
• Increased transforming growth factor alpha expression observed in both experimental and human liver tumors.
• Transgenic mice with transforming growth factor alpha and c-myc genes exhibited increased tumor incidence.

Conclusions:

• Animal models are valuable for understanding liver tumor development and identifying biomarkers.
• Fish hepatocarcinogenesis models are useful for assessing environmental pollutants' impact on liver health.
• Comparative analysis of experimental models and human lesions enhances the study of premalignant and malignant liver diseases.